PMID: 7017196Jan 1, 1981

Clinical studies on cefadroxil in pediatrics (author's transl)

The Japanese journal of antibiotics
I TerashimaS Uehara

Abstract

The present paper reports the results which were obtained in a clinical trial of cefadroxil (CDX), a new oral cephalosporin, in the pediatric field. (1) A total of 20 patients with infectious diseases including 9 urinary tract infection, 7 acute tonsillitis, 2 scarlet fever, 1 pyodermia and 1 recurrent bronchitis were treated with CDX. Of the 20 cases, the clinical response was excellent in 15 cases (75%), good in 4 cases (20%), and fair in 1 case (5%). (2) Efficacy classified by causative organisms was as follows; E. coli, 100%; S. pyogenes, 87.5%. (3) Neither adverse reactions nor abnormal laboratory results were observed.

Related Concepts

Teens
Age Factors
Bacterial Infections
Ultracef
Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer
Clinical Trials
Antibiotic Resistance, Microbial
Acute Tonsillitis
Bronchitis
Cefadroxil

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

The Japanese journal of antibiotics
H MikawaT Yoshimura
The Japanese journal of antibiotics
T Sekiguchi, T Okamoto
The Japanese journal of antibiotics
T NishimuraM Takagi
© 2021 Meta ULC. All rights reserved